
Virginia Tech collaboration with Chilean university will address earthquakes, other challenges
Researchers and administrators from Austral University of Chile will visit Virginia Tech this week to finalize plans for joint research projects.

Researchers and administrators from Austral University of Chile will visit Virginia Tech this week to finalize plans for joint research projects.

A new study conducted by education researchers at the University of Virginia finds that about one-third of Virginia students lack at least one important element of readiness for kindergarten.

Governor Terry McAuliffe announced Wednesday that Canon Virginia, Inc. (CVI), a wholly owned subsidiary of Canon U.S.A., Inc., will invest $100 million to expand its operation in the City of Newport News.

The Route 29 Project Delivery Advisory Panel will hold its first meeting of the new year at 2 p.m. Thursday at the Virginia Center for Transportation Innovation and Research, 530 Edgemont Road, Charlottesville.

Town Hall wrote this week on the recent Jim Webb news regarding payments from his Born Fighting PAC to family members with the suggestion that the news bit could have come from Team Clinton’s oppo research efforts.

The Virginia Tech Transportation Institute will host approximately 400 transportation experts from around the world at the ninth International Conference on Managing Pavement Assets to be held in Arlington, Virginia, this May 18 through 21.

At the beginning of a new year, we stand at the cusp of possibility. We have the chance for a fresh start. And though the start of the New Year may not bring with it a completely blank slate, it at least offers an opportunity to recalibrate.

Going “fat-free” might seem like an effective, safe way to lose weight when considering that fat contains nine calories per gram, compared to four calories per gram in carbohydrates and proteins.

A study of 3,000 people in the USA has found that December is the month when people are most distracted by browsing the internet at work.

A protein called GRP78 could be a universal therapeutic target for treating human diseases like brain cancer, Ebola, Influenza, Hepatitis and superbug bacteria such as MRSE and MRSA, according to a Virginia Commonwealth University-led pre-clinical study published this month in the Journal of Cellular Physiology.
Local news is in “serious jeopardy,” according to experts. Pitch in and help AFP continue to deliver news to the Valley, Virginia and beyond.